Radiation sensitizers, such as ChT, oxygen mimics, or metallic NPs in combination with ionizing radiation, are used increasingly more in NSCLC to improve the outcome for those receiving radiation therapy. This evidence concerns the gene SLC5A7 and non-small cell lung carcinoma.